Your Health, We Care
Entretinib, as a targeted drug targeting NTRK gene fusion and other specific gene mutations, continues to make progress in international research.
Entrectinib can cross the blood-brain barrier and has therapeutic effects on primary and metastatic brain diseases, which has been validated in studies targeting ROS1 fusion positive non-small cell lung cancer (NSCLC) patients.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
